Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients

Simple item page
dc.contributor.authorOrakwe, D.E.
dc.contributor.authorTijani, K.H.
dc.contributor.authorJeje, E.A.
dc.contributor.authorOgunjimi, M.A.
dc.contributor.authorOjewola, R.W.
dc.date.accessioned2020-02-24T07:41:29Z
dc.date.available2020-02-24T07:41:29Z
dc.date.issued2017-01
dc.descriptionStaff publicationsen_US
dc.description.abstractObjectives: To compare serum testosterone and prostate specific antigen (PSA) levels of patients diagnosed of prostate cancer to those with benign prostatic hyperplasia (BPH). Subjects and methods: One hundred and thirteen male patients with or without LUTS who had indica- tion(s) for prostate biopsies were recruited. Blood samples were analysed for serum testosterone and serum PSA. Prostate sizes were measured and PSA densities calculated before trans-rectal prostate biopsies were performed. Results: On histology of prostate biopsy specimens, 54 patients (47.8%) had prostate adenocarcinoma while 59 patients (52.2%) had BPH. Serum testosterone levels were lower in the prostate cancer group (23.09 ± 2.31 nmol/L versus 24.37 ± 1.94 nmol/L in the BPH group) but this difference was not statistically significant (p = 0.671). Serum testosterone also did not differ significantly with Gleason grade and Gleason score in patients with prostate cancer. Serum PSA and PSA density (PSAD) values were significantly higher in men with prostate cancer, and also in prostate cancer patients with high grade disease. Conclusion: Serum testosterone levels of patients with prostate cancer did not significantly differ from those of patients with BPH and were not related to grade in prostate cancer patients.en_US
dc.identifier.citationOrakwe D.E, Tijani K.H., Jeje E.A., Ogunjimi M.A. & Ojewola R.W. Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients. Nig Postgrad Med J. 2017. Vol 23;105–108.en_US
dc.identifier.otherhttp://dx.doi.org/10.1016/j.afju.2016.03.004
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/7792
dc.language.isoenen_US
dc.publisherElserviers; Pan African Urological Urological Surgeon's Association (PAUSA)en_US
dc.relation.ispartofseriesNig Postgrad Med J.;Vol.23
dc.subjectProstate canceren_US
dc.subjectTestosteroneen_US
dc.subjectPatientsen_US
dc.subjectBenign prostatic hyperplasiaen_US
dc.subjectResearch Subject Categories::MEDICINE::Surgeryen_US
dc.titleComparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patientsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Pre-testosterone in BPH and Ca Prostate.pdf
Size:
466.8 KB
Format:
Adobe Portable Document Format
Description:
Main Article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Surgery- Scholarly Publications